Persistent exaggerated granulomatous hypersensitivity reaction to Mycobacterium indicus pranii immunomodulatory therapy for COVID-19 sepsis
Main Authors: | Nikhil Mehta, Mehul Tyagi, Iftekhar Khan, Neena Khanna |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2023-01-01
|
Series: | Indian Journal of Dermatology |
Online Access: | http://www.e-ijd.org/article.asp?issn=0019-5154;year=2023;volume=68;issue=1;spage=95;epage=96;aulast=Mehta |
Similar Items
-
Granulomatous dermatitis post Mycobacterium Indicus Pranii (MIP) vaccine in severe covid-19 infection: an exaggerated hypersensitivity phenomenon
by: Pooja Agarwal, et al.
Published: (2024-01-01) -
“Mycobacterium indicus pranii” Is a Strain of Mycobacterium intracellulare
by: David C. Alexander, et al.
Published: (2015-05-01) -
Polyphasic taxonomic analysis establishes Mycobacterium indicus pranii as a distinct species.
by: Vikram Saini, et al.
Published: (2009-07-01) -
Pyoderma Gangrenosum Following Mycobacterium Indicus pranii Vaccination for COVID-19 Infection
by: Sukhdeep Singh, et al.
Published: (2024-10-01) -
Mycobacterium indicus pranii vaccination-induced cutaneous granuloma in COVID-19 patients
by: Yapamakula Anisha Amarnath, et al.
Published: (2023-01-01)